Markus Laube

930 total citations
65 papers, 729 citations indexed

About

Markus Laube is a scholar working on Radiology, Nuclear Medicine and Imaging, Pharmacology and Oncology. According to data from OpenAlex, Markus Laube has authored 65 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Pharmacology and 18 papers in Oncology. Recurrent topics in Markus Laube's work include Radiopharmaceutical Chemistry and Applications (26 papers), Boron Compounds in Chemistry (17 papers) and Inflammatory mediators and NSAID effects (17 papers). Markus Laube is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (26 papers), Boron Compounds in Chemistry (17 papers) and Inflammatory mediators and NSAID effects (17 papers). Markus Laube collaborates with scholars based in Germany, Serbia and Canada. Markus Laube's co-authors include Jens Pietzsch, Torsten Knieß, Evamarie Hey‐Hawkins, Peter Lönnecke, Danijela Maksimović‐Ivanić, Sanja Mijatović, Christoph Tondera, Frank Wuest, Christin Neuber and Jörg Steinbach and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Markus Laube

58 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Laube Germany 17 232 177 165 163 134 65 729
Puja Panwar Hazari India 17 315 1.4× 227 1.3× 32 0.2× 65 0.4× 72 0.5× 70 826
Jiřina Vávrová Czechia 19 231 1.0× 656 3.7× 73 0.4× 120 0.7× 295 2.2× 98 1.2k
Daniela Fraier United Kingdom 14 80 0.3× 496 2.8× 63 0.4× 172 1.1× 220 1.6× 27 1.2k
Jean-Robert Deverre France 12 140 0.6× 295 1.7× 38 0.2× 56 0.3× 43 0.3× 16 690
Nilantha Bandara United States 12 127 0.5× 107 0.6× 47 0.3× 40 0.2× 79 0.6× 21 452
Jagdish K. Jaiswal New Zealand 17 90 0.4× 266 1.5× 45 0.3× 63 0.4× 53 0.4× 39 903
Sifei Han Australia 17 426 1.8× 511 2.9× 50 0.3× 134 0.8× 783 5.8× 28 1.6k
Hikmat N. Daghestani United States 11 41 0.2× 244 1.4× 127 0.8× 147 0.9× 143 1.1× 16 818
Daniel E. Levy United States 14 90 0.4× 516 2.9× 44 0.3× 292 1.8× 122 0.9× 32 1.0k
Gopal Pathuri United States 12 72 0.3× 198 1.1× 28 0.2× 62 0.4× 91 0.7× 44 487

Countries citing papers authored by Markus Laube

Since Specialization
Citations

This map shows the geographic impact of Markus Laube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Laube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Laube more than expected).

Fields of papers citing papers by Markus Laube

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Laube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Laube. The network helps show where Markus Laube may publish in the future.

Co-authorship network of co-authors of Markus Laube

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Laube. A scholar is included among the top collaborators of Markus Laube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Laube. Markus Laube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laube, Markus, et al.. (2025). Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index. ChemMedChem. 20(11). e202500166–e202500166. 3 indexed citations
2.
Wodtke, Robert, Kristof Zarschler, Markus Laube, et al.. (2025). In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency. Pharmaceuticals. 18(11). 1656–1656.
3.
Nirwan, Sonam, Markus Laube, Jens Pietzsch, et al.. (2024). Carborane Conjugates with Ibuprofen, Fenoprofen and Flurbiprofen: Synthesis, Characterization, COX Inhibition Potential and In Vitro Activity. ChemMedChem. 20(1). e202400018–e202400018. 3 indexed citations
4.
5.
Laube, Markus, Peter Lönnecke, Menyhárt B. Sárosi, et al.. (2024). Re-design and evaluation of diclofenac-based carborane-substituted prodrugs and their anti-cancer potential. Scientific Reports. 14(1). 30488–30488. 3 indexed citations
6.
Krüger‐Genge, Anne, Susanne Köhler, Markus Laube, et al.. (2023). Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis. Cells. 12(15). 1965–1965. 7 indexed citations
7.
Mata, Eduardo Sergio Oliveros, Markus Laube, Anja Feldmann, et al.. (2023). Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies. ACS Sensors. 8(2). 576–586. 29 indexed citations
8.
Paskaš, Svetlana, Markus Laube, Sven George, et al.. (2023). Carborane‐Based Tebufelone Analogs and Their Biological Evaluation In Vitro. ChemMedChem. 18(14). e202300206–e202300206. 4 indexed citations
9.
Laube, Markus, Sven George, Bettina Hofmann, et al.. (2023). Synthesis and In Vitro Biological Evaluation of p-Carborane-Based Di-tert-butylphenol Analogs. Molecules. 28(11). 4547–4547. 6 indexed citations
10.
Schöler, Andrea, et al.. (2023). Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors. Molecules. 28(3). 1061–1061. 4 indexed citations
11.
Laube, Markus, et al.. (2023). Shell engineering in soft alginate‐based capsules for culturing liver spheroids. Biotechnology Journal. 18(6). e2200365–e2200365. 6 indexed citations
12.
Laube, Markus, Peter Lönnecke, Sanja Mijatović, et al.. (2023). Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents. Advanced Therapeutics. 6(8). 5 indexed citations
13.
Paskaš, Svetlana, Markus Laube, Sven George, et al.. (2022). In Vitro Cytostatic Effect on Tumor Cells by Carborane‐Based Dual Cyclooxygenase‐2 and 5‐Lipoxygenase Inhibitors. Advanced Therapeutics. 6(4). 5 indexed citations
14.
Brandt, Florian, Markus Laube, Martin Ullrich, et al.. (2022). Sulfur [18F]Fluoride Exchange Reaction Enables Rapid Access to 18F-Labeled PET Tracers. SHILAP Revista de lepidopterología. 127–127. 1 indexed citations
15.
Paskaš, Svetlana, Menyhárt B. Sárosi, Markus Laube, et al.. (2020). Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells. Scientific Reports. 10(1). 4827–4827. 19 indexed citations
16.
Paskaš, Svetlana, Menyhárt B. Sárosi, Markus Laube, et al.. (2019). Cover Feature: Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines (ChemMedChem 3/2019). ChemMedChem. 14(3). 290–290. 1 indexed citations
17.
Knieß, Torsten, Markus Laube, & Jörg Steinbach. (2017). “Hydrous 18 F-fluoroethylation” – Leaving off the azeotropic drying. Applied Radiation and Isotopes. 127. 260–268. 7 indexed citations
18.
Tondera, Christoph, Markus Laube, Christin Neuber, et al.. (2015). Optical imaging of COX-2: Studies on an autofluorescent 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitor. Biochemical and Biophysical Research Communications. 458(1). 40–45. 12 indexed citations
19.
Laube, Markus, Wilma Neumann, M. Scholz, et al.. (2013). 2‐Carbaborane‐3‐phenyl‐1H‐indoles—Synthesis via McMurry Reaction and Cyclooxygenase (COX) Inhibition Activity. ChemMedChem. 8(2). 329–335. 23 indexed citations
20.
Knieß, Torsten, Markus Laube, Ralf Bergmann, et al.. (2012). Radiosynthesis of a 18F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo. Bioorganic & Medicinal Chemistry. 20(11). 3410–3421. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Puja Panwar Hazari Breakdown of academic impact, for papers by Jiřina Vávrová Breakdown of academic impact, for papers by Daniela Fraier Breakdown of academic impact, for papers by Jean-Robert Deverre Breakdown of academic impact, for papers by Nilantha Bandara Breakdown of academic impact, for papers by Jagdish K. Jaiswal Breakdown of academic impact, for papers by Sifei Han Breakdown of academic impact, for papers by Hikmat N. Daghestani Breakdown of academic impact, for papers by Daniel E. Levy Breakdown of academic impact, for papers by Gopal Pathuri
Rankless by CCL
2026